A Tale of Two Periods: The Evolution of Determinants and CVD Mortality Risk in Metastatic NSCLC

Background: Immunotherapy has redefined the treatment era for metastatic non-small cell lung cancer (NSCLC); therefore, this study aimed to explore trends in survival and cardiovascular disease (CVD) mortality risk before and after the widespread adoption of immunotherapy....

ver descrição completa

Detalhes bibliográficos

Principais autores:	Junyan Xia, Yanting Pang, Yiqiu Yang, Jun Teng, Qian Lin
Formato:	Artigo
Idioma:	Inglês
Publicado em:	IMR Press 2025-09-01
coleção:	Reviews in Cardiovascular Medicine
Assuntos:	non-small cell lung cancer seer database immunotherapy cardiovascular mortality risk accelerated failure time model cdc-wonder database
Acesso em linha:	https://www.imrpress.com/journal/RCM/26/9/10.31083/RCM39296
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!